semaglutide

head to head against clash football helmets fight combat
Biotech

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

BrightGene beat semaglutide on a blood sugar endpoint, giving momentum as it barrels toward a readout from a head-to-head trial against tirzepatide.
Nick Paul Taylor Jun 23, 2025 2:30pm
Eli Lilly

Lilly's oral GLP-1 delivers Ozempic-like efficacy in phase 3

Apr 17, 2025 6:45am
obesity overweight weight loss weigh

Novo links CagriSema to 16% weight loss, sending stock down

Mar 10, 2025 9:30am
finance numbers tape money

Novo stock crashes after CagriSema misses weight-loss goal

Dec 20, 2024 8:15am
gym

Macrocyclic peptides preserve muscle in mice given semaglutide

Dec 12, 2024 12:45pm
Close up of horse legs and hooves running on sand track

Biolexis enters small molecule into oral GLP-1 horse race

Sep 13, 2024 12:24pm